As both the combination screen and ATPlite assays showed that PEV did not synergize with TOP2 and PARP inhibitors and other DNA damaging agents (Supplementary Data Fig. 1d), we hypothesized that PEV sensitizes CRC cells to TOP1 inhibitors by specifically inhibiting the repair of TOP1-induced DNA damage. This evidence concerns the gene TOP2A and colorectal carcinoma.